Endometrial Cancer

Showing NaN - NaN of 75

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Cancer, Endometrial Cancer, Hereditary Cancer Syndromes Trial in New York

Recruiting
  • Colorectal Cancer
  • +2 more
    • New York, New York
      NYP/Weill Cornell Medicine
    Oct 17, 2023

    Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

    Recruiting
    • Endometrial Cancer
    • +8 more
    • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
    • Orlando, Florida
    • +21 more
    Feb 2, 2023

    Triple Negative Breast Cancer, Breast Cancer, Endometrial Cancer Trial in New York, Fairfax, Spokane (XMT-1660)

    Recruiting
    • Triple Negative Breast Cancer
    • +5 more
    • Orange, California
    • +6 more
    Jan 23, 2023

    Endometrial Cancer Who Receive Standard Treatment for Their

    Recruiting
    • Endometrial Cancer
    • +2 more
    • Physical exam
    • Hartford, Connecticut
    • +19 more
    Jan 19, 2023

    Endometrial Cancer, Stage III Endometrial Cancer, Stage III Endometrial Carcinoma Trial in United States (Intensity-modulated

    Recruiting
    • Endometrial Cancer
    • +4 more
    • Intensity-modulated radiation therapy
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 10, 2023

    Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

    Completed
    • Ovarian Cancer
    • +7 more
    • Enapotamab vedotin (HuMax-AXL-ADC)
    • Phoenix, Arizona
    • +40 more
    Dec 12, 2022

    Cervical Cancer, Endometrial Cancer Trial in United States (18F-Fluorodeoxyglucose (18F-FDG), PET/CT imaging, PET/MRI imaging)

    Active, not recruiting
    • Cervical Cancer
    • Endometrial Cancer
    • 18F-Fluorodeoxyglucose (18F-FDG)
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 3, 2023

    Choosing Ovarian Preservation or Removal Before Surgery for

    Recruiting
    • Endometrial Cancer
    • Impact of Event Scale-Revised
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Dec 22, 2022

    Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)

    Active, not recruiting
    • Advanced Solid Malignancy
    • +13 more
    • Los Angeles, California
    • +33 more
    Dec 22, 2022

    Advanced or Metastatic Solid Tumors, Lung Cancer, Breast Cancer Trial in United States (NC318)

    Active, not recruiting
    • Advanced or Metastatic Solid Tumors
    • +8 more
    • Los Angeles, California
    • +5 more
    Nov 29, 2022

    Endometrial Cancer Trial in United States (Facilitated group support, 1:1 Peer Support)

    Recruiting
    • Endometrial Cancer
    • Facilitated group support
    • 1:1 Peer Support
    • Little Rock, Arkansas
    • +6 more
    Oct 26, 2022

    Endometrial Cancer, Recurrent Endometrial Cancer Trial in United States (LY3023414)

    Completed
    • Endometrial Cancer
    • Recurrent Endometrial Cancer
    • Basking Ridge, New Jersey
    • +5 more
    Sep 13, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

    Recruiting
    • Ovarian Cancer
    • +68 more
    • Phoenix, Arizona
    • +8 more
    Aug 18, 2022

    Endometrial Cancer Trial in Worldwide (Selinexor, Matching for selinexor)

    Active, not recruiting
    • Endometrial Cancer
    • Tucson, Arizona
    • +104 more
    Aug 11, 2022

    Risk Factors for Endometrial Cancer in Black Women

    Active, not recruiting
    • Endometrial Cancer
    • questionnaire administration
    • +2 more
    • Bronx, New York
    • +3 more
    Aug 9, 2022

    NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • Tucson, Arizona
    • +26 more
    Aug 1, 2022

    Endometrial Cancer Trial in Worldwide (retifanlimab, epacadostat, pemigatinib)

    Recruiting
    • Endometrial Cancer
    • Anchorage, Alaska
    • +78 more
    Jul 25, 2022

    Endometrial Cancer, Endometrial Cancer Recurrent, Lung Cancer Recurrent Trial in United States (RGX-104, Nivolumab, Ipilimumab)

    Recruiting
    • Endometrial Cancer
    • +5 more
    • Los Angeles, California
    • +13 more
    Jul 21, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • +12 more
    • San Francisco, California
    • +44 more
    Jul 12, 2022

    Endometrial Cancer Trial in United States (Intensity modulated radiation therapy (IMRT), Dostarlimab)

    Recruiting
    • Endometrial Cancer
    • Basking Ridge, New Jersey
    • +6 more
    Jul 5, 2022

    Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)

    Recruiting
    • Endometrial Cancer
    • Atezolizumab - 28 Day Cycle
    • +6 more
    • Duarte, California
    • +13 more
    Jun 8, 2022